​

InMode (INMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INMD Stock Forecast

InMode (INMD) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $26.00, with a high of $27.00 and a low of $25.00. This represents a 44.77% increase from the last price of $17.96.

$15 $18 $21 $24 $27 $30 High: $27 Avg: $26 Low: $25 Last Closed Price: $17.96

INMD Stock Rating

InMode stock's rating consensus is Hold, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (33.33%), 3 Hold (50.00%), 1 Sell (16.67%), and 0 Strong Sell (0.00%).

Hold
Total 6 0 1 3 2 Strong Sell Sell Hold Buy Strong Buy

INMD Price Target Upside V Benchmarks

TypeNameUpside
StockInMode44.77%
SectorHealthcare Stocks 25.00%
IndustryMedical Device Stocks6.94%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$21.40
Last Closing Price$17.96$17.96$17.96
Upside/Downside--19.15%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25124--7
Jan, 25124--7
Dec, 24124--7
Nov, 24124--7
Oct, 24124--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 16, 2024Sam ElberBTIG$25.00$16.8848.10%39.20%
Oct 12, 2024Matt MiksicBarclays$27.00$16.5063.64%50.33%
Jul 23, 2024Matthew TaylorJefferies$19.00$17.757.04%5.79%
Jul 12, 2024Caitlin CroninCanaccord Genuity$16.00$16.82-4.88%-10.91%
May 03, 2024Danielle AntalffyUBS$20.00$17.3615.21%11.36%
Oct 13, 2023Caitlin CroninCanaccord Genuity$22.00$20.756.02%22.49%
Dec 21, 2022Barclays$44.00$35.2224.93%144.99%
May 03, 2022Needham$58.00$25.61126.47%222.94%
Feb 11, 2022Matthew TaylorUBS$90.00$47.0191.45%401.11%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 16, 2024BTIGBuyinitialise
Oct 12, 2024BarclaysOverweightOverweighthold
Oct 01, 2024Canaccord GenuityHoldHoldhold
Jul 23, 2024JefferiesHolddowngrade
May 03, 2024UBSNeutralNeutralhold
Oct 13, 2023Canaccord GenuityBuyHolddowngrade
Feb 17, 2023NeedhamBuyNegativedowngrade
Dec 21, 2022BarclaysOverweightinitialise
Jun 30, 2022Canaccord GenuityBuyBuyhold
May 03, 2022NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.04$2.03$1.96$2.37----
Avg Forecast$0.89$1.98$2.31$2.52$1.86$1.98$2.20$2.33
High Forecast$0.86$1.93$2.27$2.44$1.81$1.92$1.82$2.26
Low Forecast$0.91$2.04$2.44$2.64$1.95$2.07$2.65$2.44
Surprise %16.85%2.53%-15.15%-5.95%----

Revenue Forecast

$150M $290M $430M $570M $710M $850M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$206.11M$357.56M$454.27M$492.05M----
Avg Forecast$201.68M$352.00M$450.39M$490.13M$406.09M$413.47M$437.82M$816.30M
High Forecast$197.65M$344.96M$443.51M$478.44M$396.41M$403.61M$431.21M$796.83M
Low Forecast$206.49M$360.40M$469.74M$507.98M$420.88M$428.53M$444.43M$846.02M
Surprise %2.19%1.58%0.86%0.39%----

Net Income Forecast

$50M $90M $130M $170M $210M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$75.03M$164.97M$161.52M$197.92M----
Avg Forecast$97.38M$170.42M$113.83M$197.92M$161.49M$171.58M$173.38M$200.27M
High Forecast$77.91M$165.99M$91.07M$158.34M$155.21M$164.91M$156.10M$194.06M
Low Forecast$116.86M$175.71M$136.60M$237.50M$167.76M$178.24M$227.46M$209.75M
Surprise %-22.95%-3.20%41.89%-----

INMD Forecast FAQ

Is InMode stock a buy?

InMode stock has a consensus rating of Hold, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that InMode is a neutral investment for most analysts.

What is InMode's price target?

InMode's price target, set by 6 Wall Street analysts, averages $26 over the next 12 months. The price target range spans from $25 at the low end to $27 at the high end, suggesting a potential 44.77% change from the previous closing price of $17.96.

How does InMode stock forecast compare to its benchmarks?

InMode's stock forecast shows a 44.77% upside, outperforming the average forecast for the healthcare stocks sector (25.00%) and outperforming the medical device stocks industry (6.94%).

What is the breakdown of analyst ratings for InMode over the past three months?

  • February 2025: 14.29% Strong Buy, 28.57% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 14.29% Strong Buy, 28.57% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 14.29% Strong Buy, 28.57% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.

What is InMode’s EPS forecast?

InMode's average annual EPS forecast for its fiscal year ending in December is $1.86 for 2024, a -21.52% decrease from the reported $2.37 in 2023. The prediction for 2025 is $1.98, $2.2 for 2026, and $2.33 for 2027.

What is InMode’s revenue forecast?

InMode's average annual revenue forecast for its fiscal year ending in December is $406.09M for 2024, a -17.47% decrease from the reported $492.05M in 2023. The forecast for 2025 is $413.47M, $437.82M for 2026, and $816.3M for 2027.

What is InMode’s net income forecast?

For its fiscal year ending in December, InMode's average annual net income forecast is $161.49M for 2024, reflecting a -18.41% decrease from the reported $197.92M in 2023. The projection for 2025 is $171.58M, $173.38M for 2026, and $200.27M for 2027.